ANITA MCDONALD: Open Payments
NPI 1336442680 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,396 in 108 payments from 29 companies in 2025. Trend: 2023 $274 · 2024 $1,198 · 2025 $2,396
Food & beverage: $1,699Long term medical supply or device loan: $598Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $745 |
| AstraZeneca Pharmaceuticals LP | 10 | $211 |
| GlaxoSmithKline, LLC. | 13 | $201 |
| Daiichi Sankyo Inc. | 9 | $157 |
| BeOne Medicines USA, Inc. | 8 | $143 |
| Merck Sharp & Dohme LLC | 6 | $139 |
| PFIZER INC. | 15 | $105 |
| SEAGEN INC. | 1 | $99 |
| EMD Serono, Inc. | 2 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
Products named: KISQALI, Enhertu, KEYTRUDA, BRUKINSA, IMFINZI, JEMPERLI, ZEJULA, BESREMI.
Industry payments across UT — which companies pay providers there.
